Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway

Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway

Bibliographic Details
Main Authors: Wang Zhi, Qiao Bao, Li Guo, Li Shi, Wang Li, Dong Ying
Format: Article
Language:English
Published: De Gruyter 2014-05-01
Series:Open Life Sciences
Subjects:
bevacizumab
amd
tlr2
rpe
Online Access:https://doi.org/10.2478/s11535-014-0290-5
id doaj-789676a21551485eb3144e9008b6b2f1
record_format Article
spelling doaj-789676a21551485eb3144e9008b6b2f12021-09-05T21:03:17ZengDe GruyterOpen Life Sciences2391-54122014-05-019546947510.2478/s11535-014-0290-5s11535-014-0290-5Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathwayWang Zhi0Qiao Bao1Li Guo2Li Shi3Wang Li4Dong Ying5Henan Eye Institute, Henan Eye Hospital, Zhengzhou, 450003, ChinaThe Second People’s Hospital of Zhengzhou, Zhengzhou, 450006, ChinaThe Eye Hospital of Wenzhou Medical University, Wenzhou, ChinaHenan Eye Institute, Henan Eye Hospital, Zhengzhou, 450003, ChinaHenan Eye Institute, Henan Eye Hospital, Zhengzhou, 450003, ChinaHenan Eye Institute, Henan Eye Hospital, Zhengzhou, 450003, Chinahttps://doi.org/10.2478/s11535-014-0290-5bevacizumabamdtlr2rpe
collection DOAJ
language English
format Article
sources DOAJ
author Wang Zhi
Qiao Bao
Li Guo
Li Shi
Wang Li
Dong Ying
spellingShingle Wang Zhi
Qiao Bao
Li Guo
Li Shi
Wang Li
Dong Ying
Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
Open Life Sciences
bevacizumab
amd
tlr2
rpe
author_facet Wang Zhi
Qiao Bao
Li Guo
Li Shi
Wang Li
Dong Ying
author_sort Wang Zhi
title Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
title_short Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
title_full Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
title_fullStr Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
title_full_unstemmed Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
title_sort bevacizumab cured age-related macular degeneration (amd) via down-regulate tlr2 pathway
publisher De Gruyter
series Open Life Sciences
issn 2391-5412
publishDate 2014-05-01
topic bevacizumab
amd
tlr2
rpe
url https://doi.org/10.2478/s11535-014-0290-5
work_keys_str_mv AT wangzhi bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
AT qiaobao bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
AT liguo bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
AT lishi bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
AT wangli bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
AT dongying bevacizumabcuredagerelatedmaculardegenerationamdviadownregulatetlr2pathway
_version_ 1717781022759714816

Similar Items